GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » Net Income Including Noncontrolling Interests

Indegene (NSE:INDGN) Net Income Including Noncontrolling Interests : ₹4,067 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indegene Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Indegene's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ₹1,176 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ₹4,067 Mil.

Indegene Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Indegene's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Net Income Including Noncontrolling Interests Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Net Income Including Noncontrolling Interests
1,494.13 1,628.18 2,661.00 3,367.00 4,067.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 948.00 877.00 917.00 1,097.00 1,176.00

Indegene Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,067 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indegene Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Indegene's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Indegene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
NSE:SAGILITY NSE:IKS BOM:538837 NSE:DHTL VEEV GEHC ASX:PME TEM DOCS TSE:2413 HQY WAY BTSG HKSE:02587 HNGE SZSE:300253 PRVA HKSE:02228 PINC HKSE:01833
Traded in Other Exchanges
544172:India
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Website
https://www.indegene.com
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines